{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:46Z","timestamp":1792686346467,"version":"4.5.0"},"reference-count":66,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jmsacl.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:03:25Z","timestamp":1648501405000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical interpretation of serum hepcidin-25 in inflammation and renal dysfunction"],"prefix":"10.21627","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-5205","authenticated-orcid":false,"given":"Michael X.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Kuehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Mattman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Van der Gugten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"8","key":"10.1016\/j.jmsacl.2022.03.002_b0005","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2011-11-391219","article-title":"Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children","volume":"119","author":"Prentice","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jmsacl.2022.03.002_b0010","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jmsacl.2022.03.002_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0020","doi-asserted-by":"crossref","unstructured":"Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr. 2009;89(2):533-8.","DOI":"10.3945\/ajcn.2008.26589"},{"issue":"1","key":"10.1016\/j.jmsacl.2022.03.002_b0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3324\/haematol.11705","article-title":"Hepcidin: from discovery to differential diagnosis","volume":"93","author":"Kemna","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jmsacl.2022.03.002_b0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/10408363.2015.1038744","article-title":"Diagnosis of iron-deficient states","volume":"52","author":"Archer","year":"2015","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"23","key":"10.1016\/j.jmsacl.2022.03.002_b0035","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","article-title":"Hepcidin in the diagnosis of iron disorders","volume":"127","author":"Girelli","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jmsacl.2022.03.002_b0040","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications","volume":"57","author":"Kroot","year":"2011","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.jmsacl.2022.03.002_b0045","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0050","doi-asserted-by":"crossref","unstructured":"Koliaraki V, Marinou M, Vassilakopoulos TP, Vavourakis E, Tsochatzis E, Pangalis GA, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4(2):e4581.","DOI":"10.1371\/journal.pone.0004581"},{"issue":"5","key":"10.1016\/j.jmsacl.2022.03.002_b0055","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00535-010-0344-z","article-title":"A novel monoclonal antibody immunoassay for the detection of human serum hepcidin","volume":"46","author":"Schwarz","year":"2011","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.jmsacl.2022.03.002_b0060","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1373\/clinchem.2013.208371","article-title":"Novel circulating isoforms of hepcidin","volume":"59","author":"Moe","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2022.03.002_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jprot.2012.08.006","article-title":"Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study","volume":"76","author":"Campostrini","year":"2012","journal-title":"J. Proteomics"},{"issue":"Suppl 1","key":"10.1016\/j.jmsacl.2022.03.002_b0070","article-title":"A sensitive and cost-effective high-performance liquid chromatography\/tandem mass spectrometry (multiple reaction monitoring) method for the clinical measurement of serum hepcidin","volume":"34","author":"Chen","year":"2020","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jmsacl.2022.03.002_b0075","doi-asserted-by":"crossref","unstructured":"van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, et al. Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material. Clin Chem. 2016;62(7):993-1001.","DOI":"10.1373\/clinchem.2016.256768"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0080","doi-asserted-by":"crossref","unstructured":"Diepeveen LE, Laarakkers CMM, Martos G, Pawlak ME, Uguz FF, Verberne K, et al. Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material. Clin Chem Lab Med. 2019;57(6):864-72.","DOI":"10.1515\/cclm-2018-0783"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0085","doi-asserted-by":"crossref","unstructured":"Aune ET, Diepeveen LE, Laarakkers CM, Klaver S, Armitage AE, Bansal S, et al. Optimizing hepcidin measurement with a proficiency test framework and standardization improvement. Clin Chem Lab Med. 2020;59(2):315-23.","DOI":"10.1515\/cclm-2020-0928"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0090","doi-asserted-by":"crossref","unstructured":"Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806-10.","DOI":"10.1074\/jbc.M008922200"},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0095","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1373\/clinchem.2006.079186","article-title":"Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications","volume":"53","author":"Kemna","year":"2007","journal-title":"Clin. Chem."},{"issue":"25","key":"10.1016\/j.jmsacl.2022.03.002_b0100","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","article-title":"Serum hepcidin: reference ranges and biochemical correlates in the general population","volume":"117","author":"Galesloot","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jmsacl.2022.03.002_b0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2009.03.039","article-title":"(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies","volume":"389","author":"Kroot","year":"2009","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.jmsacl.2022.03.002_b0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.2011.141","article-title":"Hepcidin: clinical utility as a diagnostic tool and therapeutic target","volume":"80","author":"Coyne","year":"2011","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Epstein","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jmsacl.2022.03.002_b0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/joe.1.05729","article-title":"The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney","volume":"184","author":"Kulaksiz","year":"2005","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.2008.316","article-title":"Biomarkers of lupus nephritis determined by serial urine proteomics","volume":"74","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.jmsacl.2022.03.002_b0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5045\/br.2013.48.1.10","article-title":"Role of hepcidin in the pathophysiology and diagnosis of anemia","volume":"48","author":"D'Angelo","year":"2013","journal-title":"Blood Res."},{"issue":"19","key":"10.1016\/j.jmsacl.2022.03.002_b0135","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Longo","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0736-4679(99)00135-3","article-title":"The C-reactive protein","volume":"17","author":"Clyne","year":"1999","journal-title":"J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.jmsacl.2022.03.002_b0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jmsacl.2022.03.002_b0150","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jmsacl.2022.03.002_b0155","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000148980.87579.5E","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group","volume":"110","author":"Myers","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jmsacl.2022.03.002_b0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jmsacl.2022.03.002_b0165","doi-asserted-by":"crossref","unstructured":"Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, et al. Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS One. 2013;8(10):e75518.","DOI":"10.1371\/journal.pone.0075518"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0170","doi-asserted-by":"crossref","unstructured":"Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570-9.","DOI":"10.1373\/clinchem.2010.149187"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0175","doi-asserted-by":"crossref","unstructured":"Busti F, Campostrini N, Martinelli N, Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol. 2014;5:83.","DOI":"10.3389\/fphar.2014.00083"},{"issue":"25","key":"10.1016\/j.jmsacl.2022.03.002_b0180","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1182\/blood-2014-01-548776","article-title":"Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis","volume":"123","author":"Donker","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jmsacl.2022.03.002_b0185","first-page":"1321","article-title":"Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies","volume":"35","author":"De Falco","year":"2014","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.jmsacl.2022.03.002_b0190","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.3324\/haematol.2014.115733","article-title":"Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and beta-thalassemia intermedia","volume":"100","author":"Origa","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jmsacl.2022.03.002_b0195","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2141.2008.07273.x","article-title":"Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels","volume":"142","author":"van Dijk","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.jmsacl.2022.03.002_b0205","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00535-010-0259-8","article-title":"Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders","volume":"45","author":"Kaneko","year":"2010","journal-title":"J Gastroenterol."},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0210","first-page":"727","article-title":"Hepcidin and iron-loading anemias","volume":"91","author":"Nemeth","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jmsacl.2022.03.002_b0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2009-04-216226","article-title":"Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation","volume":"114","author":"Sham","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.seminhematol.2015.07.004","article-title":"Anemia of chronic disorders: new diagnostic tools and new treatment strategies","volume":"52","author":"Weiss","year":"2015","journal-title":"Semin. Hematol."},{"issue":"12","key":"10.1016\/j.jmsacl.2022.03.002_b0225","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/art.30623","article-title":"Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia","volume":"63","author":"van Santen","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"235","key":"10.1016\/j.jmsacl.2022.03.002_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008249","article-title":"Expression of the iron hormone hepcidin distinguishes different types of anemia in African children","volume":"6","author":"Pasricha","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jmsacl.2022.03.002_b0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.23354","article-title":"Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia","volume":"88","author":"Bregman","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"23","key":"10.1016\/j.jmsacl.2022.03.002_b0240","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2015-03-636407","article-title":"Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia","volume":"125","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0245","doi-asserted-by":"crossref","unstructured":"Minutolo R, Locatelli F, Gallieni M, Bonofiglio R, Fuiano G, Oldrizzi L, et al. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. Nephrol Dial Transplant. 2013;28(12):3035-45.","DOI":"10.1093\/ndt\/gft338"},{"key":"10.1016\/j.jmsacl.2022.03.002_b0250","doi-asserted-by":"crossref","unstructured":"Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, et al. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One. 2014;9(6):e99781.","DOI":"10.1371\/journal.pone.0099781"},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0255","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jmsacl.2022.03.002_b0260","doi-asserted-by":"crossref","unstructured":"Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One. 2008;3(7):e2706.","DOI":"10.1371\/journal.pone.0002706"},{"issue":"3","key":"10.1016\/j.jmsacl.2022.03.002_b0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.2009.07758.x","article-title":"High-sensitive radioimmunoassay for human serum hepcidin","volume":"146","author":"Grebenchtchikov","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.jmsacl.2022.03.002_b0270","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/09674845.2009.11730263","article-title":"Development of a novel immunoassay for the iron regulatory peptide hepcidin","volume":"66","author":"Busbridge","year":"2009","journal-title":"Br. J. Biomed. Sci."},{"issue":"10","key":"10.1016\/j.jmsacl.2022.03.002_b0275","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ajh.23289","article-title":"Second round robin for plasma hepcidin methods: first steps toward harmonization","volume":"87","author":"Kroot","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/pr.2014.109","article-title":"Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5-3 y","volume":"76","author":"Uijterschout","year":"2014","journal-title":"Pediatr. Res."},{"issue":"9","key":"10.1016\/j.jmsacl.2022.03.002_b0285","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.jmsacl.2022.03.002_b0290","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"Peters","year":"2010","journal-title":"Nephrol. Dial Transplant."},{"issue":"8","key":"10.1016\/j.jmsacl.2022.03.002_b0295","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.2010.254","article-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","volume":"78","author":"Ford","year":"2010","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.jmsacl.2022.03.002_b0300","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.jmsacl.2022.03.002_b0305","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.jmsacl.2022.03.002_b0310","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0315","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood-2005-10-4043","article-title":"Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System","volume":"108","author":"Tomosugi","year":"2006","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jmsacl.2022.03.002_b0320","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3889\/oamjms.2019.636","article-title":"The relation between serum hepcidin, ferritin, hepcidin: ferritin ratio, hydroxyurea and splenectomy in children with beta-thalassemia","volume":"7","author":"Ismail","year":"2019","journal-title":"Open Access Maced J. Med. Sci."},{"issue":"6","key":"10.1016\/j.jmsacl.2022.03.002_b0325","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/0929867327666200207120158","article-title":"Serum hepcidin, the hepcidin\/ferritin ratio and the risk of type 2 diabetes: a systematic review and meta-analysis","volume":"28","author":"Karamzad","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.jmsacl.2022.03.002_b0330","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/1744-9987.12773","article-title":"Hepcidin\/ferritin ratios differ among non-dialyzed chronic kidney disease patients, and patients on hemodialysis and peritoneal dialysis","volume":"23","author":"Niikura","year":"2019","journal-title":"Therapeutic apheresis and dialysis."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X22000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X22000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:30Z","timestamp":1767770550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X22000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":66,"alternative-id":["S2667145X22000074"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2022.03.002","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical interpretation of serum hepcidin-25 in inflammation and renal dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}